This educational program consists of three presentations on risk reduction in ASCVD.

This course consists of the following:

• Mechanistic clues to understanding the benefits of icosapent ethyl - Prof. Matthew Budoff, MD - Los Angeles, CA, USA
• Tackling risk reduction in ASCVD: A clinical case - Prof. Lawrence Leiter, MD - Toronto, ON, Canada
• Addressing late-breaking data on triglycerides, fibrates and omega-3 FAs - Prof. Peter Libby, MD (Boston, MA, USA), Prof. Gabriel Steg, MD (Paris, France), and Prof. Kausik Ray, MD (London, UK)

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Describe the study results seen with EPA and the combination of EPA and DHA
• Explain the potential mechanisms behind the effect of EPA on plaque progression
• Describe the place of icosapent ethyl in ASCVD risk management
• Recall the main results of the PROMINENT and RESPECT-EPA trials
• Name at least 2 ways to overcome clinical inertia with regard to reducing ASCVD risk

Expert faculty

• Prof. Matthew Budoff, MD - Los Angeles, CA, USA
• Prof. Lawrence Leiter, MD - Toronto, ON, Canada
• Prof. Peter Libby, MD - Boston, MA, USA
• Prof. Gabriel Steg, MD - Paris, France
• Prof. Kausik Ray, MD - London, UK

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with ASCVD.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from Amarin.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.